The Leadership Team at Liquidia is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative therapies for pulmonary arterial hypertension (PAH), and ensuring operational efficiencies across all departments. This team collaborates on key decisions, financial management, and market strategies to drive growth and address unmet patient needs effectively.